Scopus by Title (Ref)

Low Prevalence of Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) in a Hospital Triage Population in Tehran During 2024–2025

Health Science Reports

August 2026

Letafati A.

Open Access

How serious is the risk of HTLV-1 infection in Iranian hemodialysis-dependent patients?

BMC Nephrology

December 2025

Mohammaditabar M.

Open Access

Human T-lymphotropic virus-1 proviral load among patients on maintenance hemodialysis

Medical Journal of Malaysia

July 2025

Al-Jubouri Z.S.

Active Human T-lymphotropic Virus Type-1 Antigenemia in a Sample of Iraqi Patients on Maintenance Hemodialysis

Al Kindy College Medical Journal

1 April 2025

Al-Jubouri Z.S.

Open Access

Perspectives on the Mature T-Cell Lymphomas in the Middle East: A Comprehensive Review of the Present Status

Cancers

December 2024

Al-Mansour M.

Open Access

High Human T-Cell Leukemia Virus Type 1c Proviral Loads Are Associated With Diabetes and Chronic Kidney Disease: Results of a Cross-Sectional Community Survey in Central Australia

Clinical Infectious Diseases

1 February 2023

Talukder M.R.

Updates on the Epidemiology of the Human T-Cell Leukemia Virus Type 1 Infection in the Countries of the Eastern Mediterranean Regional Office of the World Health Organization with Special Emphasis on the Situation in Iran

Viruses

April 2022

Hedayati-Moghaddam M.R.

Open Access

Risk factors for HTLV-1, acute kidney injury, and urinary tract infection among aboriginal adults with end stage kidney disease in central Australia

Journal of Medical Virology

November 2021

Talukder M.R.

Higher human T-cell leukaemia virus type 1 (HTLV-1) proviral load is associated with end-stage kidney disease in Indigenous Australians: Results of a case-control study in central Australia

Journal of Medical Virology

October 2019

Talukder M.R.R.